A carregar...

Treatment with tumour necrosis factor α antagonists in patients with rheumatoid arthritis induces anticardiolipin antibodies

Objective: To determine the frequency and clinical impact of anticardiolipin antibodies (aCL) in patients with rheumatoid arthritis treated with infliximab and etanercept. Methods: 121 patients from the Stockholm tumour necrosis factor α (TNFα) follow up registry (STURE) treated with infliximab or e...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Jonsdottir, T, Forslid, J, van Vollenhoven, A, Harju, A, Brannemark, S, Klareskog, L, van Vollenhoven, R F
Formato: Artigo
Idioma:Inglês
Publicado em: 2004
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1755142/
https://ncbi.nlm.nih.gov/pubmed/15066863
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2003.018093
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!